Quick answers
- What is Micardis HCT?
- Micardis HCT is a brand name of Telmisartan and hydrochlorothiazide, a prescription medicine. The FDA NDC Directory lists 3 Micardis HCT products in 3 strengths and forms.
- Who makes Micardis HCT?
- Boehringer Ingelheim holds the FDA application for Micardis HCT (NDA021162, approved November 17, 2000).
- Is there a generic or store brand of Micardis HCT?
- Yes. The FDA NDC Directory lists 24 other products with the same active ingredients, strength and form as a Micardis HCT product, 24 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Micardis HCT?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Micardis HCT strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Micardis HCT been recalled?
- No recall linked to Micardis HCT products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Micardis HCT is
Each Micardis HCT product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Telmisartan and hydrochlorothiazide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| hydrochlorothiazide 12.5 mg · telmisartan 40 mg tablet (oral) | Micardis HCT | 8 products, 8 companies | DailyMed |
| hydrochlorothiazide 12.5 mg · telmisartan 80 mg tablet (oral) | Micardis HCT | 8 products, 8 companies | DailyMed |
| hydrochlorothiazide 25 mg · telmisartan 80 mg tablet (oral) | Micardis HCT | 8 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Telmisartan and hydrochlorothiazide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021162 | Boehringer Ingelheim | November 17, 2000 | 3 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| hydrochlorothiazide 12.5 mg · telmisartan 40 mg tablet | Brand: Micardis HCT | $4.48 per tablet Generic of the same strength and form: $0.3483 per tablet |
| hydrochlorothiazide 12.5 mg · telmisartan 80 mg tablet | Brand: Micardis HCT | $4.47 per tablet Generic of the same strength and form: $0.3329 per tablet |
| hydrochlorothiazide 25 mg · telmisartan 80 mg tablet | Brand: Micardis HCT | $4.48 per tablet Generic of the same strength and form: $0.3438 per tablet |
NADAC list of November 4, 2026; these prices took effect between January 21, 2026 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Micardis HCT
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Micardis HCT products.
Recalls
No recall linked to Micardis HCT products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.